近年，東亞國家開始參與國際合成生物學的研究。但是，與西方國家相比，東亞國家的發展還是相對慢。這也令到公眾接收合成生物學的資訊比較少。因此，我們希望透過這個檔案令更多人關注合成生物學在香港、中國、日本、韓國和印尼的發展。檔案包括了與合成生物學或生物科技有關的資訊：市場、投資、法例、公眾的看法、研究和活動。
希望透過這個檔案，能令你對合成生物學和生物科技的發展有更大的關注和了解。
Development up to now has mostly been centered in the West, in countries such as the United States and the United Kingdom, with Japan being East Asia’s one of the early adopters. In more recent years, other East Asian countries have begun to participate on the international synthetic biology stage. But in comparison to western countries, synthetic biology in East Asian countries is still in its infancy. The result is a disparity in information available to the public about synthetic biology developments in these respective regions. In the interests of amending this situation, we present this document as a reference for progress in synthetic biology in the four East Asian countries/regions and one South East Asian country: Hong Kong, China, South Korea, Japan, and Indonesia. It includes investigations into research achievements, public perception, regulations and funding that we conducted using local online search engines and our native languages that will hopefully provide with the inside story.
We hope that you can know more about synthetic biology and biotechnology development through this profile.
中文版本:
香港 中國 日本 韓國 印尼 English version:
沒有留言:
發佈留言